Two ScFv antibody libraries derived from identical VL-VH framework with different binding site designs display distinct binding profiles. 2013

Tuomas Huovinen, and Markku Syrjänpää, and Hanna Sanmark, and Eeva-Christine Brockmann, and Alex Azhayev, and Qi Wang, and Markus Vehniäinen, and Urpo Lamminmäki
Department of Biochemistry and Food Chemistry, University of Turku, 20520 Turku, Finland.

In directed evolution experiments, a single randomization scheme of an antibody gene does not provide optimal diversity for recognition of all sizes of antigens. In this study, we have expanded the recognition potential of our universal library, termed ScFvP, with a second distinct diversification scheme. In the second library, termed ScFvM, diversity was designed closer to the center of the antigen binding site in the same antibody framework as earlier. Also, the CDR-H3 loop structures were redesigned to be shorter, 5-12 aa and mostly without the canonical salt bridge between Arg106H and Asp116H to increase the flexibility of the loop and to allow more space in the center of the paratope for binding smaller targets. Antibodies were selected from the two libraries against various antigens separately and as a mixture. The origin and characteristics of the retrieved antibodies indicate that complementary diversity results in complementary functionality widening the spectrum of targets amenable for selection.

UI MeSH Term Description Entries
D007147 Immunoglobulin Light Chains Polypeptide chains, consisting of 211 to 217 amino acid residues and having a molecular weight of approximately 22 kDa. There are two major types of light chains, kappa and lambda. Two Ig light chains and two Ig heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) make one immunoglobulin molecule. Ig Light Chains,Immunoglobulins, Light-Chain,Immunoglobulin Light Chain,Immunoglobulin Light-Chain,Light-Chain Immunoglobulins,Chains, Ig Light,Chains, Immunoglobulin Light,Immunoglobulins, Light Chain,Light Chain Immunoglobulins,Light Chain, Immunoglobulin,Light Chains, Ig,Light Chains, Immunoglobulin,Light-Chain, Immunoglobulin
D008387 Marine Toxins Toxic or poisonous substances elaborated by marine flora or fauna. They include also specific, characterized poisons or toxins for which there is no more specific heading, like those from poisonous FISHES. Marine Biotoxins,Phycotoxins
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D004076 Digoxigenin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide. A cardenolide which is the aglycon of digoxin. Can be obtained by hydrolysis of digoxin or from Digitalis orientalis L. and Digitalis lanata Ehrh. Lanadigenin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D017430 Prostate-Specific Antigen A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer. Kallikrein hK3,gamma-Seminoprotein,hK3 Kallikrein,Prostate Specific Antigen,Semenogelase,Seminin,Kallikrein, hK3,gamma Seminoprotein

Related Publications

Tuomas Huovinen, and Markku Syrjänpää, and Hanna Sanmark, and Eeva-Christine Brockmann, and Alex Azhayev, and Qi Wang, and Markus Vehniäinen, and Urpo Lamminmäki
June 2010, Journal of neuroimmunology,
Tuomas Huovinen, and Markku Syrjänpää, and Hanna Sanmark, and Eeva-Christine Brockmann, and Alex Azhayev, and Qi Wang, and Markus Vehniäinen, and Urpo Lamminmäki
January 2014, mAbs,
Tuomas Huovinen, and Markku Syrjänpää, and Hanna Sanmark, and Eeva-Christine Brockmann, and Alex Azhayev, and Qi Wang, and Markus Vehniäinen, and Urpo Lamminmäki
October 2014, Journal of immunological methods,
Tuomas Huovinen, and Markku Syrjänpää, and Hanna Sanmark, and Eeva-Christine Brockmann, and Alex Azhayev, and Qi Wang, and Markus Vehniäinen, and Urpo Lamminmäki
January 1999, Methods in molecular biology (Clifton, N.J.),
Tuomas Huovinen, and Markku Syrjänpää, and Hanna Sanmark, and Eeva-Christine Brockmann, and Alex Azhayev, and Qi Wang, and Markus Vehniäinen, and Urpo Lamminmäki
January 2009, Methods in molecular biology (Clifton, N.J.),
Tuomas Huovinen, and Markku Syrjänpää, and Hanna Sanmark, and Eeva-Christine Brockmann, and Alex Azhayev, and Qi Wang, and Markus Vehniäinen, and Urpo Lamminmäki
January 1995, Nucleic acids symposium series,
Tuomas Huovinen, and Markku Syrjänpää, and Hanna Sanmark, and Eeva-Christine Brockmann, and Alex Azhayev, and Qi Wang, and Markus Vehniäinen, and Urpo Lamminmäki
January 2017, Frontiers in immunology,
Tuomas Huovinen, and Markku Syrjänpää, and Hanna Sanmark, and Eeva-Christine Brockmann, and Alex Azhayev, and Qi Wang, and Markus Vehniäinen, and Urpo Lamminmäki
July 2016, Biologicals : journal of the International Association of Biological Standardization,
Tuomas Huovinen, and Markku Syrjänpää, and Hanna Sanmark, and Eeva-Christine Brockmann, and Alex Azhayev, and Qi Wang, and Markus Vehniäinen, and Urpo Lamminmäki
March 2002, Developmental and comparative immunology,
Tuomas Huovinen, and Markku Syrjänpää, and Hanna Sanmark, and Eeva-Christine Brockmann, and Alex Azhayev, and Qi Wang, and Markus Vehniäinen, and Urpo Lamminmäki
May 2004, British journal of cancer,
Copied contents to your clipboard!